1. Home
  2. ARWR vs KEN Comparison

ARWR vs KEN Comparison

Compare ARWR & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • KEN
  • Stock Information
  • Founded
  • ARWR 2003
  • KEN 2014
  • Country
  • ARWR United States
  • KEN Singapore
  • Employees
  • ARWR N/A
  • KEN N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • KEN Electric Utilities: Central
  • Sector
  • ARWR Health Care
  • KEN Utilities
  • Exchange
  • ARWR Nasdaq
  • KEN Nasdaq
  • Market Cap
  • ARWR 1.7B
  • KEN 1.7B
  • IPO Year
  • ARWR 1993
  • KEN N/A
  • Fundamental
  • Price
  • ARWR $11.24
  • KEN $28.62
  • Analyst Decision
  • ARWR Buy
  • KEN
  • Analyst Count
  • ARWR 11
  • KEN 0
  • Target Price
  • ARWR $41.44
  • KEN N/A
  • AVG Volume (30 Days)
  • ARWR 2.3M
  • KEN 37.3K
  • Earning Date
  • ARWR 05-08-2025
  • KEN 06-02-2025
  • Dividend Yield
  • ARWR N/A
  • KEN 16.82%
  • EPS Growth
  • ARWR N/A
  • KEN N/A
  • EPS
  • ARWR N/A
  • KEN 11.34
  • Revenue
  • ARWR $2,500,000.00
  • KEN $751,304,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • KEN N/A
  • Revenue Next Year
  • ARWR $64.24
  • KEN N/A
  • P/E Ratio
  • ARWR N/A
  • KEN $2.48
  • Revenue Growth
  • ARWR N/A
  • KEN 8.60
  • 52 Week Low
  • ARWR $9.57
  • KEN $20.72
  • 52 Week High
  • ARWR $30.41
  • KEN $35.49
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 38.40
  • KEN 39.77
  • Support Level
  • ARWR $9.64
  • KEN $27.10
  • Resistance Level
  • ARWR $12.93
  • KEN $35.49
  • Average True Range (ATR)
  • ARWR 1.18
  • KEN 1.44
  • MACD
  • ARWR 0.18
  • KEN -0.49
  • Stochastic Oscillator
  • ARWR 43.21
  • KEN 18.12

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented, businesses. The company's operating segments include OPC; CPV Group; and ZIM. It generates maximum revenue from the OPC segment. OPC operates in the Israeli electricity generation sector, including initiating, developing, constructing, and operating power plants and selling and supplying electricity. Geographically, it derives a majority of its revenue from Israel.

Share on Social Networks: